Medicure (MCUJF) Non-Current Deffered Revenue (2009 - 2021)
Medicure's (MCUJF) quarterly Non-Current Deffered Revenue came in at $51566.8 in Q4 2021, down 79.93% year-on-year from $256963.3 in Q4 2020, and down 79.93% quarter-over-quarter from $256963.3 in Q4 2020.
Medicure (MCUJF) Non-Current Deffered Revenue (2009 - 2021) Analysis & Trends
Medicure's Non-Current Deffered Revenue history runs 8 years deep, the most recent figure standing at $51566.8 for Q4 2021.
- On a quarterly basis, Non-Current Deffered Revenue fell 79.93% year-over-year to $51566.8 in Q4 2021; TTM through Dec 2021 was $51566.8, a 79.93% decrease from a year earlier, with the FY2021 full-year figure at $51867.1, down 79.26% from the prior year.
- Non-Current Deffered Revenue eased to $51566.8 in Q4 2021 per MCUJF's latest filing, from $256963.3 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $2.3 million in Q4 2017 and bottomed at $51566.8 in Q4 2021.
- The 5-year median for Non-Current Deffered Revenue is $890818.1 (2019), against an average of $1.0 million.
- Across the five-year window, Non-Current Deffered Revenue retreated 16.62% in 2017 and slumped 79.93% in 2021, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $2.3 million in 2017, then tumbled by 32.73% to $1.5 million in 2018, then sank by 42.22% to $890818.1 in 2019, then slumped by 71.15% to $256963.3 in 2020, then slumped by 79.93% to $51566.8 in 2021.
- Per Business Quant, the three latest MCUJF Non-Current Deffered Revenue figures stand at $51566.8 (Q4 2021), $256963.3 (Q4 2020), and $890818.1 (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 51,566.85 |
| Dec 31, 2020 | 256,963.31 |
| Dec 31, 2019 | 890,818.07 |
| Dec 31, 2018 | 1.54 Mn |
| Dec 31, 2017 | 2.29 Mn |
| Dec 31, 2016 | 2.75 Mn |
| Aug 31, 2010 | -295,132.14 |
| May 31, 2010 | -299,948.51 |
| Feb 28, 2010 | -291,694.57 |
| Nov 30, 2009 | -288,040.43 |
| Aug 31, 2009 | -275,764.85 |
| May 31, 2009 | 34.00 Mn |
| Feb 28, 2009 | 532.00 Mn |